Ablynx IPO triumphs in challenging market

Despite a succession of postponed or cancelled biotech IPOs in the second half of 2007, venture-backed Belgian company Ablynx, focused on the discovery and development of Nanobodies, completed the largest-ever biotech IPO on Euronext Brussels, raising a total in excess of €85m last November.